Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic Malignancies
Status:
Unknown status
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of oral administration of vinorelbine
once daily for at least 7 days. The study will be conducted in subjects with a
non-hematologic malignancy for which there are no currently accepted therapies.